0KBL Stock Chart & Stats
$46.68
$0.37(0.72%)
At close: 4:00 PM EDT
$46.68
$0.37(0.72%)
Day’s Range― - ―
52-Week Range$39.29 - $52.50
Previous CloseN/A
Volume2.82K
Average Volume (3M)783.00
Market Cap
$13.47B
Enterprise Value$19.18B
Total Cash (Recent Filing)$39.04M
Total Debt (Recent Filing)$4.02B
Price to Earnings (P/E)15.4
Beta0.50
Next Earnings
Nov 03, 2026EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend Yield6%
Share Statistics
EPS (TTM)2.89
Shares Outstanding303,013,000
10 Day Avg. Volume994
30 Day Avg. Volume783
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)2.53
Price to Sales (P/S)10.96
P/FCF Ratio14.94
Enterprise Value/Market Cap1.42
Enterprise Value/Revenue14.84
Enterprise Value/Gross Profit20.63
Enterprise Value/Ebitda13.24
Forecast
1Y Price Target
$50.58Price Target Upside8.36% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)2.66
Revenue Forecast (FY)$1.09B
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability MomentumRevenue has continued to rise and TTM profitability is materially stronger, indicating improved earnings capacity. Although reported margins have been volatile, the combination of top-line momentum and higher net margin can support investment, debt service, and shareholder distributions over the next several quarters.
Deleveraging And Liquidity ImprovementMeaningful deleveraging improves financial flexibility and reduces dependence on external funding for near-term obligations. The nearly repaid revolver and stronger fixed-charge coverage provide greater capacity to manage refinancing needs, absorb operator volatility, and fund selective investments.
Higher Contractual Rent From PACS TransitionAdding the Florida portfolio to PACS’s existing master lease creates a visible increase in contractual rent, followed by recurring 2% escalators. The transition also deepens the relationship with a major operator, potentially supporting more stable cash flows and future portfolio opportunities.
Bears Say
Sharp Free-cash-flow DecelerationThe recent decline in free-cash-flow growth weakens confidence in the consistency of internally generated cash, even though the absolute level remains healthy. Lower conversion versus prior years could constrain reinvestment, debt reduction, or distributions if the deceleration persists.
Operator-specific Credit StressCoverage below 1.0x indicates that at least one operator portfolio is not fully supporting its allocated rent from operating earnings. Required facility transitions demonstrate active management, but also show that operator credit quality remains a durable source of cash-flow variability.
Meaningful Debt And Refinancing ExposureAlthough leverage has improved, the sizable debt balance leaves Omega exposed to refinancing costs and interest-rate sensitivity. Higher financing expense or less favorable capital-market access could reduce the spread between property returns and funding costs, limiting financial flexibility.
Omega Healthcare News
0KBL FAQ
What was Omega Healthcare’s price range in the past 12 months?
Omega Healthcare lowest share price was $39.29 and its highest was $52.50 in the past 12 months.
What is Omega Healthcare’s market cap?
Omega Healthcare’s market cap is $13.47B.
When is Omega Healthcare’s upcoming earnings report date?
Omega Healthcare’s upcoming earnings report date is Nov 03, 2026 which is in 10 days.
How were Omega Healthcare’s earnings last quarter?
Omega Healthcare released its earnings results on Jul 29, 2026. The company reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.509 by $0.681.
Is Omega Healthcare overvalued?
According to Wall Street analysts Omega Healthcare’s price is currently Undervalued.
Does Omega Healthcare pay dividends?
Omega Healthcare pays a Quarterly dividend of $0.68 which represents an annual dividend yield of 6%. See more information on Omega Healthcare dividends here
What is Omega Healthcare’s EPS estimate?
Omega Healthcare’s EPS estimate is 0.47.
How many shares outstanding does Omega Healthcare have?
Omega Healthcare has 303,013,000 shares outstanding.
What happened to Omega Healthcare’s price movement after its last earnings report?
Omega Healthcare reported an EPS of $1.19 in its last earnings report, beating expectations of $0.509. Following the earnings report the stock price went down -2.514%.
Which hedge fund is a major shareholder of Omega Healthcare?
Currently, no hedge funds are holding shares in GB:0KBL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Omega Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$50.58 (8.36% Upside)
$50.58 (8.36% Upside)
Blogger Sentiment
Bullish
GB:0KBL Sentiment 64%
Sector Average 63%
Sector Average 63%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.80%
12-Months-Change
Fundamentals
Return on Equity
16.51%
Trailing 12-Months
Asset Growth
-5.04%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Omega Healthcare
Omega Healthcare Investors, Inc. functions as a Real Estate Investment Trust (REIT) primarily focused on the long-term healthcare sector. The company strategically invests in properties providing skilled nursing and assisted living services. A diverse array of healthcare operators manage these assets, predominantly utilizing a triple-net lease framework. Its portfolio is geographically distributed across all regions of the United States and also includes holdings in the United Kingdom.
0KBL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong underlying fundamentals: year-over-year revenue and AFFO growth, significant liquidity and deleveraging, strategic asset sales executed at attractive economics, improved portfolio coverage, a robust investment pipeline (including first U.K. RIDEA), and a modestly tightened upward guidance. Near-term results are being muted by intentional strategic asset sales and loan repayments, and a small number of operator-specific issues (Genesis bankruptcy, Ciena transitions, localized occupancy gaps) and regulatory risks create some near-term uncertainty. Overall, management projects these actions will strengthen credit support and enable accretive redeployment in H2 2026 and 2027.View all GB:0KBL earnings summaries0KBL Stock 12 Month Forecast
Average Price Target
$50.58
▲(8.36% Upside)
Technical Analysis
Healthpeak Properties
―
Sabra Healthcare REIT
―
Healthcare Realty Trust
―
CareTrust REIT
―
American Healthcare REIT, Inc.
―